AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FENNEC PHARMACEUTICALS INC. Director's Dealing 2019

Jun 20, 2019

35599_dirs_2019-06-19_e3e3d698-c259-424b-8b45-aa6adf65e178.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2019-06-18

Reporting Person: Brughera Marco Maria (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-18	Stock Option (right to buy)	$4.26	A	20000	Acquired	2029-06-18	Common Shares (20000)	Direct

Footnotes

F1: On June 18, 2019, Marco Brughera was granted an incentive stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan.

F2: The option is 100% vested on the date of grant.